Intervention Group for Infertility
This trial will test whether a PRP infusion into the uterus can help infertile women with thin endometrium conceive via IVF.
- Uterine Infertility
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Find a site
Who is running the clinical trial?
Frequently Asked Questions
Does this experiment permit patients of a younger age to participate?
"According to the criteria for entry into this medical trial, those aged 18-45 are eligible. Separately, there exist 14 trials catered towards minors and 33 studies open exclusively to senior citizens."
How many participants are typically included in this trial?
"Affirmative. According to the clinicaltrials.gov database, this experiment is actively recruiting participants after it was first publicized on October 15th 2022 and edited most recently on October 19th 2022. This study requires 62 patients from a single trial site."
Are qualified participants still accepted for this clinical experiment?
"Indeed, the information posted on clinicaltrials.gov attests to this trial's active recruitment efforts. It was originally made available in October 15th 2022 and its most recent update happened four days later. 62 candidates are presently expected to join from a single location."
What qualifications are necessary to participate in this medical experiment?
"This trial is admitting sixty-two individuals aged between 18 and 45 that have received oxytocics. In order to be considered, participants must present a record of two cancelled embryo transfer cycles due to inadequate endometrial thickness or failure to reach sustained clinical pregnancy. Additionally, patients must demonstrate an endometrial lining no thicker than 6mm on prior unsuccessful transfers."